ClassID:

94723

C07D271/04 - CPC Classification

Classification description:

Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings 1,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Recent Application in this class:
#1
20250353853
2025-11-20

FLAVIVIRUS INHIBITORS

#2
20240408090
2024-12-12

Methods Of Treating Dyskinesia And Related Disorders

#3
20240092745
2024-03-21

DRUGS AND COMPOSITIONS FOR THE TREATMENT OF OCULAR DISORDERS

#4
20230183193
2023-06-15

4-DIFLUOROMETHYL BENZOYL AMIDES WITH HERBICIDAL ACTION

#5
20230037883
2023-02-09

Alkene-containing amide compound and application thereof

#6
20220331320
2022-10-20

Methods of treating dyskinesia and related disorders

#7
20220324814
2022-10-13

CALPAIN MODULATORS AND THERAPEUTIC USES THEREOF

#8
20220324807
2022-10-13

Aromatic sulfonamide derivatives

#9
20210107882
2021-04-15

Compound for inhibiting IDO, a manufacturing method and a use thereof

#10
20200223845
2020-07-16

Viral replication inhibitors

#11
20200207728
2020-07-02

Sulfonyl amidine as indoleamine-2,3-dioxygenase inhibitor, and preparation method therefor and use thereof

#12
20200123114
2020-04-23

Calpain modulators and therapeutic uses thereof

#13
20200115351
2020-04-16

Macromolecules comprising triazoles and related compounds

#14
20200055829
2020-02-20

4-DIFLUOROMETHYL BENZOYL AMIDES WITH HERBICIDAL ACTION

#15
20200031783
2020-01-30

Drugs and compositions for the treatment of ocular disorders

#16
20190367465
2019-12-05

Heterocyclic urea compound, and drug composition and application thereof

#17
20190352292
2019-11-21

Oxadiazole inhibitors of HIPK2 for treating kidney fibrosis

#18
20190328736
2019-10-31

Methods of treating dyskinesia and related disorders

#19
20190169140
2019-06-06

IDO1 INHIBITOR AND PREPARATION METHOD AND APPLICATION THEREOF

#20
20190144401
2019-05-16

IMINOSYDNONE DERIVATIVES FOR CONJUGATION AND RELEASE OF COMPOUNDS OF INTEREST

#21
20190127380
2019-05-02

Substituted bicyclic heterocyclic compounds

#22
20190119210
2019-04-25

Aromatic sulfonamide derivatives

#23
20180360046
2018-12-20

Benzamide compounds and their use as herbicides

#24
20180244663
2018-08-30

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

#25
20180235224
2018-08-23

Substituted ketoxime benzoylamides

#26
20180215742
2018-08-02

Proteasome chymotrypsin-like inhibition using PI-1833 analogs

#27
20180204685
2018-07-19

Dye sensitized photoelectric conversion device

#28
20170158629
2017-06-08

Herbicidally active arylcarboxylic acid amides

#29
20170129863
2017-05-11

IMINOSYDNONE DERIVATIVES FOR CONJUGATION AND RELEASE OF COMPOUNDS OF INTEREST

#30
20170081300
2017-03-23

SYDNONE DERIVATIVES FOR CONJUGATION OF COMPOUNDS OF INTEREST

#31
20170042894
2017-02-16

Methods of treating sleep disorders

#32
20160343515
2016-11-24

Organic dyes incorporating the oxadiazole moiety for efficient dye-sensitized solar cells

#33
20160297810
2016-10-13

Viral replication inhibitors

#34
20160221996
2016-08-04

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

#35
20150133674
2015-05-14

Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor

#36
20150018210
2015-01-15

Herbicidally-effective sulfinyl aminobenzamides

#37
20150018209
2015-01-15

Herbicidal 3-(sulfin-/sulfonimidoyl)-benzamides

#38
20140371231
2014-12-18

Methods of treating dyskinesia and related disorders

#39
20140206625
2014-07-24

Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions

#40
20140106969
2014-04-17

N-(1,2,5-Oxadiazol-3-yl)-, N-(tetrazol-5-yl)- and N-(triazol-5-yl)bicycloarylcarboxamides and their use as herbicides

#41
20140073650
2014-03-13

Proteasome chymotrypsin-like inhibition using PI-1833 analogs

#42
20130323271
2013-12-05

Nitric oxide donor neprilysin inhibitors

#43
20130281495
2013-10-24

Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders

#44
20130252959
2013-09-26

NITRIC OXIDE DONORS IN THERAPY OF NITRIC OXIDE DEFICIENCY-INDUCED DISTURBANCES OF CEREBRAL MICROCIRCULATION

#45
20130225561
2013-08-29

Inhibitors of the renal outer medullary potassium channel

#46
20120264717
2012-10-18

Compounds, compositions and methods comprising oxadiazole derivatives

#47
20120264698
2012-10-18

Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions

#48
20120077806
2012-03-29

Deubiquitinase inhibitors and methods for use of the same

#49
20110306621
2011-12-15

ACYLGUANIDINE DERIVATIVES

#50
20110288137
2011-11-24

Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders

#51
20110028493
2011-02-03

Heterocyclic derivative and use thereof

#52
20090281083
2009-11-12

Combination Product

#53
20090264441
2009-10-22

Compounds, compositions and methods comprising oxadiazole derivatives

#54
20090215839
2009-08-27

SYDNONIMINES-SPECIFIC DOPAMINE REUPTAKE INHIBITORS AND THEIR USE IN TREATING DOPAMINE RELATED DISORDERS

#55
20090186907
2009-07-23

Pyrazinones As Cellular Proliferation Inhibitors

#56
20080319030
2008-12-25

SYDNONIMINES - SPECIFIC DOPAMINE REUPTAKE INHIBITORS AND THEIR USE IN TREATING DOPAMINE RELATED DISORDERS

#57
20070191389
2007-08-16

Biaryl derivatives

#58
17032529
2022-05-24

Calpain modulators and therapeutic uses thereof